Evidence map›Paper›PMID 26472817›Full record

ArticleCirculation research2016

Tissue-Specific Cell Cycle Indicator Reveals Unexpected Findings for Cardiac Myocyte Proliferation.

Maretoshi Hirai, Ju Chen, Sylvia M Evans

Abstract read
In one paragraph

Article in Circulation research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Article
  3. Cardiomyocyte-fibroblast crosstalk in the postnatal heart.Frontiers in cell and developmental biology · 2023
    Review
  4. Article
  5. Article
  6. Mechanism-Based Cardiac Regeneration Strategies in Mammals.Frontiers in cell and developmental biology · 2021
    Review
  7. Article
  8. Adult Cardiomyocyte Cell Cycle Detour: Off-ramp to Quiescent Destinations.Trends in endocrinology and metabolism: TEM · 2019
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Resident fibroblast expansion during cardiac growth and remodeling.Journal of molecular and cellular cardiology · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Redirecting cardiac growth mechanisms for therapeutic regeneration.The Journal of clinical investigation · 2017
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Maretoshi HiraiFrom the Skaggs School of Pharmacy and Pharmaceutical Sciences (M.H., S.M.E.), Department of Medicine (J.C., S.M.E.), and Department of Pharmacology (S.M.E.), University of California, San Diego, La Jolla.
Ju ChenFrom the Skaggs School of Pharmacy and Pharmaceutical Sciences (M.H., S.M.E.), Department of Medicine (J.C., S.M.E.), and Department of Pharmacology (S.M.E.), University of California, San Diego, La Jolla.
Sylvia M EvansFrom the Skaggs School of Pharmacy and Pharmaceutical Sciences (M.H., S.M.E.), Department of Medicine (J.C., S.M.E.), and Department of Pharmacology (S.M.E.), University of California, San Diego, La Jolla. syevans@ucsd.edu.

Funding

U of Calif, San Diego Neuroscience Microscopy ImagingP30NS047101 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G, ZHENG, BINHAI · 2003 to 2022
$9.0M
Developmental Regulatory Genomics of Human Cardiovascular LineagesUM1HL128773 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHI, NEIL C, EVANS, SYLVIA M · 2015 to 2019
$3.8M
Approaches to Cardiac RegenerationDP1OD006428 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI EVANS, SYLVIA M · 2009 to 2011
$2.3M
The Role of Dot1L in developing and postnatal heartR01HL123747 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI EVANS, SYLVIA M · 2014 to 2017
$1.5M
Approaches to Cardiac RegenerationDP1HL117649 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI EVANS, SYLVIA M · 2012 to 2013
$1.5M
NCCDPHP CDC HHS DP1HL117649NHLBI NIH HHS DP1 HL117649NHLBI NIH HHS R01 HL123747NHLBI NIH HHS R01HL123747NHLBI NIH HHS UM1 HL128773NIH HHS DP1 OD006428NINDS NIH HHS P30 NS047101
6 · The paper itself

Abstract

rationaleDiscerning cardiac myocyte cell cycle behavior is challenging owing to commingled cell types with higher proliferative activity.

objectiveTo investigate cardiac myocyte cell cycle activity in development and the early postnatal period. METHODS AND

resultsTo facilitate studies of cell type-specific proliferation, we have generated tissue-specific cell cycle indicator BAC transgenic mouse lines. Experiments using embryonic fibroblasts from CyclinA2-LacZ-floxed-EGFP, or CyclinA2-EGFP mice, demonstrated that CyclinA2-βgal and CyclinA2-EGFP were expressed from mid-G1 to mid-M phase. Using Troponin T-Cre;CyclinA2-LacZ-EGFP mice, we examined cardiac myocyte cell cycle activity during embryogenesis and in the early postnatal period. Our data demonstrated that right ventricular cardiac myocytes exhibited reduced cell cycle activity relative to left ventricular cardiac myocytes in the immediate perinatal period. Additionally, in contrast to a recent report, we could find no evidence to support a burst of cardiac myocyte cell cycle activity at postnatal day 15.

conclusionsOur data highlight advantages of a cardiac myocyte-specific cell cycle reporter for studies of cardiac myocyte cell cycle regulation.

Indexed as

AnimalsCell CycleCell ProliferationCells, CulturedCyclin A2FemaleGreen Fluorescent ProteinsMiceMice, TransgenicMyocytes, CardiacPregnancyCCNA2 protein, mouseCyclin A2enhanced green fluorescent proteinGreen Fluorescent Proteinscardiac myocytecell cyclecyclinsheart developmentproliferation

Identifiers

PMID26472817
PMCPMC5533092

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.